April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Novel Mutations Causing Nance-Horan Syndrome and Phenotypic Variability
Author Affiliations & Notes
  • A. J. Hardcastle
    UCL Institute of Ophthalmology, London, United Kingdom
  • M. Coccia
    UCL Institute of Ophthalmology, London, United Kingdom
  • S. P. Brooks
    UCL Institute of Ophthalmology, London, United Kingdom
  • K. Christodoulou
    UCL Institute of Ophthalmology, London, United Kingdom
  • I. Russell-Eggitt
    Great Ormond Street Hospital for Children, London, United Kingdom
  • Footnotes
    Commercial Relationships  A.J. Hardcastle, None; M. Coccia, None; S.P. Brooks, None; K. Christodoulou, None; I. Russell-Eggitt, None.
  • Footnotes
    Support  Fight for Sight UK and The Wellcome Trust
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4123. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. J. Hardcastle, M. Coccia, S. P. Brooks, K. Christodoulou, I. Russell-Eggitt; Novel Mutations Causing Nance-Horan Syndrome and Phenotypic Variability. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4123.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To identify the underlying genetic basis for Nance-Horan Syndrome in a series of patients and evaluate the phenotypic variability.

Methods: : Ten families were diagnosed with Nance-Horan Syndrome (NHS). Family members were examined by clinical geneticists and ophthalmologists. DNA was extracted for mutation screening of the Nance-Horan Syndrome gene (NHS). Exons 1-8 of the NHS gene, including exons 1a, 1c and 3b were amplified and sequenced. For each mutation detected segregation was tested, where possible, and control chromosomes screened.

Results: : All ten affected families had typical features of NHS including congenital cataract, dental anomalies and dysmorphism. Disease in six families was attributed to a protein truncation mutation in the NHS gene in exons 1a, 2, 3, 6 or 8. No mutations were identified in the remaining four families. Of the six families with NHS gene mutations, two had developmental delay and other phenotypes in this patient group included delayed motor development and bilateral hearing loss.

Conclusions: : We have identified novel mutations in the NHS gene causing Nance-Horan Syndrome. Variability of phenotype was noted, with symptoms not previously associated with NHS. Currently, it is not clear what leads to variability of phenotype but age of diagnosis, genetic and environmental factors may all play a role. This is the first report of a mutation in either exon 2 or exon 8 of the NHS gene. Four families with clinical features of NHS lack a molecular diagnosis, which suggests that NHS may be genetically heterogeneous, or that mutations lie outside known coding exons.

Keywords: cataract • genetics • gene screening 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×